The 7 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 7.00, with a high estimate of 15.00 and a low estimate of 6.00. The median estimate represents a +33.08% increase from the last price of 5.26.
The current consensus among 8 polled investment analysts is to Sell stock in Puma Biotechnology Inc. This rating has held steady since October, when it was downgraded from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.31
Reporting Date Nov 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.